In vitro assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines.
Gwenaëlle MahieuAnne-Laure SennesaelLionel PochetVincent HaufroidFrançoise Van BambekeAnne SpinewineLaure ElensPublished in: Research and practice in thrombosis and haemostasis (2024)
Our study does not provide evidence for a possible interaction between tacrolimus and rivaroxaban when used together in practice.